SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024803
Filing Date
2024-06-21
Accepted
2024-06-21 17:22:48
Documents
17
Period of Report
2024-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47494
2 ex1-1.htm EX-1.1 250845
3 ex5-1.htm EX-5.1 23583
4 ex5-1_001.jpg GRAPHIC 6193
5 ex5-1_002.jpg GRAPHIC 2069
  Complete submission text file 0001493152-24-024803.txt   566793

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE jan-20240621.xsd EX-101.SCH 3006
7 XBRL LABEL FILE jan-20240621_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE jan-20240621_pre.xml EX-101.PRE 22354
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3684
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241061432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)